Advanced Oxygen (AOXY) 10-Q2025 Q1 Quarterly report

Filed: 4 Nov 24, 6:07am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	7th grade Avg

New words: component, local, separate

Removed: adverse, adversely, announced, clinical, continue, declaration, delay, deploy, disrupt, distancing, economy, effectively, emergency, endemic, expire, extent, fit, global, government, health, indefinite, kr, limited, longer, magnitude, manufacturing, marketplace, monitoring, ongoing, predict, public, recoverability, relating, remain, research, secured, situation, social, staffing, threat, unable, uncertain, weighted, workforce, World

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AOXY similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Advanced Oxygen Technologies, Inc. (the “Company”) on Form 10-Q for the 3 month period ended September 30, 2024 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert Wolfe, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2024	By:	/s/ Robert Wolfe
		Robert Wolfe
		Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.